![Devin Leake](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Devin Leake
Director/Board Member at
Novalis Lifesciences LLC
Profile
Devin Leake is currently the Managing Director at Novalis Lifesciences LLC.
Previously, he held positions as the Director-Global Molecular Biology R&D at Thermo Fisher Scientific, Inc., Vice President-Research & Development at Gen9, Inc., Scientist at Dharmacon, Inc., and Venture Partner at Sapir Venture Partners LLC.
He also served as a Board Advisor at Enzymit Ltd. from 2020 to 2021.
Dr. Leake obtained a doctorate degree from Stony Brook University in 1999 and also holds a doctorate degree from The State University of New York.
He completed his undergraduate studies at The University of Texas at Austin in 1993.
Devin Leake active positions
| Companies | Position | Start |
|---|---|---|
Novalis Lifesciences LLC
 Novalis Lifesciences LLC Investment ManagersFinance Novalis Lifesciences invests in small to medium size companies located in the United States. The firm focuses on a broad range of sectors and industries. It provides financing for early stage transactions. | Director/Board Member | 01/12/2021 |
Former positions of Devin Leake
| Companies | Position | End |
|---|---|---|
Sapir Venture Partners LLC
 Sapir Venture Partners LLC Investment ManagersFinance Sapir Venture Partners invests in companies located in Israel and the United States, primarily in Boston and New York. The firm targets companies operating in the fields of deep-technology, biotech, science, and AI sectors. It participates in pre-seed capital requirements. | Private Equity Investor | 01/12/2021 |
Enzymit Ltd.
 Enzymit Ltd. Medical SpecialtiesHealth Technology Develops enzymes | Consultant / Advisor | 01/11/2021 |
Gen9, Inc.
 Gen9, Inc. BiotechnologyHealth Technology Develops synthetic biology technologies | Chief Operating Officer | - |
| THERMO FISHER SCIENTIFIC, INC. | Corporate Officer/Principal | - |
Dharmacon, Inc.
 Dharmacon, Inc. Miscellaneous Commercial ServicesCommercial Services Develops and commercializes new technology for RNA oligonucleotide synthesis | Corporate Officer/Principal | - |
Training of Devin Leake
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
96
1st degree connections
9
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 9 |
|---|---|
Gen9, Inc.
Gen9, Inc. BiotechnologyHealth Technology Develops synthetic biology technologies | Health Technology |
Dharmacon, Inc.
Dharmacon, Inc. Miscellaneous Commercial ServicesCommercial Services Develops and commercializes new technology for RNA oligonucleotide synthesis | Commercial Services |
Stony Brook University
 Stony Brook University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Texas at Austin
 The University of Texas at Austin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The State University of New York
 The State University of New York Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Thermo Fisher Scientific, Inc.
 Thermo Fisher Scientific, Inc. Medical SpecialtiesHealth Technology Develops, manufactures and markets analytical and environment monitoring instruments | Health Technology |
Sapir Venture Partners LLC
Sapir Venture Partners LLC Investment ManagersFinance Sapir Venture Partners invests in companies located in Israel and the United States, primarily in Boston and New York. The firm targets companies operating in the fields of deep-technology, biotech, science, and AI sectors. It participates in pre-seed capital requirements. | Finance |
Novalis Lifesciences LLC
Novalis Lifesciences LLC Investment ManagersFinance Novalis Lifesciences invests in small to medium size companies located in the United States. The firm focuses on a broad range of sectors and industries. It provides financing for early stage transactions. | Finance |
Enzymit Ltd.
Enzymit Ltd. Medical SpecialtiesHealth Technology Develops enzymes | Health Technology |
- Stock Market
- Insiders
- Devin Leake
